MICROPORT CARDIOFLOW MEDTECH CORPORATION Funds and ETFs MicroPort CardioFlow Medtech Corporation
Equities
2160
KYG6082P1054
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.03 HKD | +5.10% |
|
+11.96% | -36.42% |
| Apr. 16 | Microport Cardioflow Inks Services Deal with Subsidiary | MT |
| Apr. 15 | MicroPort CardioFlow Medtech Corporation Enters into the 2024 MP CardioAdvent Service Procurement Framework Agreement | CI |
ETFs positioned on MicroPort CardioFlow Medtech Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
Microport Cardioflow Medtech Corp is a China-based investment holding company mainly engaged in the medical device industry. The Company is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The Company's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The Company mainly conducts business within the domestic market.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9534
CNY
Average target price
2.412
CNY
Spread / Average Target
+153.01%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.42% | 317M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- 2160 Stock
- Funds and ETFs MicroPort CardioFlow Medtech Corporation
